Our analysis reveals three core insights: First, biomarker mechanisms are now well-defined across species, with diagnostic tools like CRP in canine sepsis, prognostic indicators such as cfDNA in oncology, and predictive signatures like BRAF in melanoma enabling more targeted interventions. This evidence concerns the gene BRAF and melanoma.